Patent · US Active

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

US8715640B2 · kind B2 · utility

5Cited by
28References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 15, 2010
Grant dateMay 6, 2014
Priority date
Expiry dateJan 15, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions are provided for delivery of a polynucleotide encoding a gene of interest, typically an antigen, to a dendritic cell (DC). The virus envelope comprises a DC-SIGN specific targeting molecule. The methods and related compositions can be used to treat patients suffering from a wide range of conditions, including infection, such as HIV/AIDS, and various types of cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.